Recombinant human interleukin-2 became available for clinical use in the mid 1980s. Recent years have seen an enormous amount of clinical research with this cytokine and interleukin-2 has now been registered for use in a number of European countries for the treatment of metastatic renal cell carcinoma. This book is designed to provide the clinical oncologist wishing to use interleukin-2 with a basic background concerning the biology of the agent, a discussion concerning practical aspects, of its clinical use including management of toxicity and an overview of the clinical results together with a description of how this internesting cytokine might be developed in the future.
| Author: J. Wagstaff |
| Publisher: Springer |
| Publication Date: Oct 29, 2012 |
| Number of Pages: 191 pages |
| Binding: Paperback or Softback |
| ISBN-10: 9401047693 |
| ISBN-13: 9789401047692 |
